Hellinida Thomadaki

发表

Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11

A. Scorilas, M. Talieri, K. Mavridis, 2009, Thrombosis and Haemostasis.

Cisplatin‐Induced Apoptosis in HL‐60 Human Promyelocytic Leukemia Cells

A. Scorilas, M. Talieri, N. Katsaros, 2003, Annals of the New York Academy of Sciences.

Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.

A. Scorilas, N. Tosic, M. Čolović, 2012, Clinical Biochemistry.

Home Genes Leukemias Tumors Cancer prone Deep Insight Case Reports Portal Journals Teaching X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

A. Scorilas, C. Kontos, A. Turhan, 2009 .

Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS

A. Scorilas, M. Talieri, Hellinida Thomadaki, 2006, Biological chemistry.

Alterations in mRNA Expression of Apoptosis‐Related Genes BCL2, BAX, FAS, Caspase‐3, and the Novel Member BCL2L12 after Treatment of Human Leukemic Cell Line HL60 with the Antineoplastic Agent Etoposide

A. Scorilas, M. Talieri, Dimitra Florou, 2006, Annals of the New York Academy of Sciences.

Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine.

A. Scorilas, C. Raptopoulou, E. Efthimiadou, 2007, Journal of inorganic biochemistry.

Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.

A. Scorilas, C. Litos, Hellinida Thomadaki, 2007, Journal of medicinal chemistry.

Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction

A. Scorilas, C. Tsiapalis, Hellinida Thomadaki, 2005, Biological chemistry.

mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin

A. Scorilas, M. Talieri, N. Katsaros, 2004, Biological chemistry.

Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex.

A. Scorilas, Alexandra Lymberopoulou-Karaliota, Hellinida Thomadaki, 2011, Journal of inorganic biochemistry.

Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol

A. Scorilas, Hellinida Thomadaki, 2008, Biological chemistry.

Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines.

A. Scorilas, C. Litos, Hellinida Thomadaki, 2008, Journal of medicinal chemistry.

BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer

Andreas Scorilas, A. Scorilas, Hellinida Thomadaki, 2006, Critical reviews in clinical laboratory sciences.

The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines

A. Scorilas, C. Tsiapalis, Hellinida Thomadaki, 2008, Cancer Chemotherapy and Pharmacology.

The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner

A. Scorilas, M. Havredaki, C. Tsiapalis, 2007, Cancer Chemotherapy and Pharmacology.

Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.

Andreas Scorilas, A. Scorilas, M. Talieri, 2007, Cancer letters.

BCL2L12 (BCL2-like 12 (proline-rich))

A. Scorilas, C. Kontos, Hellinida Thomadaki, 2011 .

The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

A. Scorilas, T. Economopoulos, S. Papageorgiou, 2011, The oncologist.

Molecular Response of HL‐60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis‐Related Gene Expressions, Including the New Member BCL2L12

A. Scorilas, K. Floros, Hellinida Thomadaki, 2009, Annals of the New York Academy of Sciences.

Atlas of Genetics and Cytogenetics in Oncology and Haematology

A. Scorilas, C. Kontos, Hellinida Thomadaki, 2009 .

Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis‐Related Genes, Including the New Member, BCL2L12

A. Scorilas, Hellinida Thomadaki, 2007, Annals of the New York Academy of Sciences.

Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells

A. Scorilas, N. Katsaros, Hellinida Thomadaki, 2007, Biological chemistry.

Molecular Profile of the BCL2 Family of the Apoptosis Related Genes in Breast Cancer Cells after Treatment with Cytotoxic/Cytostatic Drugs

A. Scorilas, Hellinida Thomadaki, 2008, Connective tissue research.

NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS Molecular Response of HL-60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis-Related Gene Expressions, Including the New Member BCL2L12

A. Scorilas, K. Floros, Hellinida Thomadaki, 2009 .